User:Mr. Ibrahem/Lasmiditan

Lasmiditan, sold under the brand name Reyvow, is a medication used to treat migraine headaches. It is not useful for prevention. It is taken by mouth. It is less effective and more expensive than sumatriptan.

Common side effects include dizziness, tiredness, and numbness. Other side effects may include serotonin syndrome, medication overuse headaches, and poor coordination. It has a low risk for misuse. Safety in pregnancy is unclear. It is a 5-HT1F receptor activator.

Lasmiditan was approved for medical use in the United States in 2019. In the United States it costs about 83 USD per 100 mg dose as of 2021. It is not available in the United Kingdom or Europe as of 2021.